Opinion and evidence in neurology and psychiatry

CNS Drugs. 2003;17(4):285-91. doi: 10.2165/00023210-200317040-00008.
No abstract available

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use
  • Humans
  • Migraine Disorders / drug therapy
  • Migraine Disorders / economics
  • Nervous System Diseases* / drug therapy
  • Neurology* / methods
  • Neurology* / trends
  • Parkinson Disease / drug therapy
  • Patient Education as Topic
  • Psychiatry* / methods
  • Psychiatry* / trends
  • Quality of Life
  • Risk Factors

Substances

  • Antidepressive Agents, Second-Generation